Literature DB >> 21102475

An old emperor finds new clothing: rejuvenation in our time.

David J Handelsman1.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 21102475      PMCID: PMC3739386          DOI: 10.1038/aja.2010.154

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  45 in total

1.  Brown-Séquard revisited: a lesson from history on the placebo effect of androgen treatment.

Authors:  Andrea J Cussons; Chotoo I Bhagat; Stephen J Fletcher; John P Walsh
Journal:  Med J Aust       Date:  2002 Dec 2-16       Impact factor: 7.738

2.  Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study.

Authors:  Abdelouahid Tajar; Gianni Forti; Terence W O'Neill; David M Lee; Alan J Silman; Joseph D Finn; György Bartfai; Steven Boonen; Felipe F Casanueva; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Fernand Labrie; Michael E J Lean; Neil Pendleton; Margus Punab; Dirk Vanderschueren; Ilpo T Huhtaniemi; Frederick C W Wu
Journal:  J Clin Endocrinol Metab       Date:  2010-02-19       Impact factor: 5.958

3.  The intended and unintended consequences of clinical guidelines.

Authors:  Rebecca J Shackelton; Lisa D Marceau; Carol L Link; John B McKinlay
Journal:  J Eval Clin Pract       Date:  2009-12       Impact factor: 2.431

Review 4.  Androgens and cardiovascular disease.

Authors:  Bu B Yeap
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

5.  Validity of estimating non-sex hormone-binding globulin bound testosterone and oestradiol from total hormone measurements in boys and girls.

Authors:  Brian L Egleston; D Walt Chandler; Joanne F Dorgan
Journal:  Ann Clin Biochem       Date:  2010-04-20       Impact factor: 2.057

Review 6.  Late-life onset hypogonadism: a review.

Authors:  Nazem Bassil; John E Morley
Journal:  Clin Geriatr Med       Date:  2010-05       Impact factor: 3.076

Review 7.  Testosterone and type 2 diabetes.

Authors:  Mathis Grossmann; Emily J Gianatti; Jeffrey D Zajac
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

8.  Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study.

Authors:  Giuseppe Caminiti; Maurizio Volterrani; Ferdinando Iellamo; Giuseppe Marazzi; Rosalba Massaro; Marco Miceli; Caterina Mammi; Massimo Piepoli; Massimo Fini; Giuseppe M C Rosano
Journal:  J Am Coll Cardiol       Date:  2009-09-01       Impact factor: 24.094

Review 9.  Obesity and testicular function.

Authors:  P M Mah; G A Wittert
Journal:  Mol Cell Endocrinol       Date:  2009-06-18       Impact factor: 4.102

Review 10.  Welcoming low testosterone as a cardiovascular risk factor.

Authors:  M Maggio; S Basaria
Journal:  Int J Impot Res       Date:  2009-06-18       Impact factor: 2.896

View more
  3 in total

1.  Premature decline of serum total testosterone in HIV-infected men in the HAART-era.

Authors:  Vincenzo Rochira; Lucia Zirilli; Gabriella Orlando; Daniele Santi; Giulia Brigante; Chiara Diazzi; Federica Carli; Cesare Carani; Giovanni Guaraldi
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

2.  Prevalence of hypogonadism in young obese males.

Authors:  Anup Halappanavar; Rajeev Pakhetra
Journal:  Clin Med (Lond)       Date:  2020-03       Impact factor: 5.410

Review 3.  Lowered testosterone in male obesity: mechanisms, morbidity and management.

Authors:  Mark Ng Tang Fui; Philippe Dupuis; Mathis Grossmann
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.